200 related articles for article (PubMed ID: 34768995)
21. Cytogenetic studies in subgroups of rhabdomyosarcoma.
Whang-Peng J; Knutsen T; Theil K; Horowitz ME; Triche T
Genes Chromosomes Cancer; 1992 Nov; 5(4):299-310. PubMed ID: 1283318
[TBL] [Abstract][Full Text] [Related]
22. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
23. Pleomorphic Sarcomas: The State of the Art.
Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F
Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449
[TBL] [Abstract][Full Text] [Related]
24. Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.
De Vita A; Recine F; Mercatali L; Miserocchi G; Spadazzi C; Liverani C; Bongiovanni A; Pieri F; Casadei R; Riva N; Fausti V; Amadori D; Ibrahim T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292724
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.
Li Z; Yu X; Shen J; Liu Y; Chan MT; Wu WK
Cell Prolif; 2015 Oct; 48(5):511-6. PubMed ID: 26202219
[TBL] [Abstract][Full Text] [Related]
26. Soft tissue sarcoma in children: prognosis and management.
Koscielniak E; Morgan M; Treuner J
Paediatr Drugs; 2002; 4(1):21-8. PubMed ID: 11817983
[TBL] [Abstract][Full Text] [Related]
27. MiRNAs as Players in Rhabdomyosarcoma Development.
Gasparini P; Ferrari A; Casanova M; Limido F; Massimino M; Sozzi G; Fortunato O
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752446
[TBL] [Abstract][Full Text] [Related]
28. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.
Stock N; Chibon F; Binh MB; Terrier P; Michels JJ; Valo I; Robin YM; Guillou L; Ranchère-Vince D; Decouvelaere AV; Collin F; Birtwisle-Peyrottes I; Gregoire F; Aurias A; Coindre JM
Am J Surg Pathol; 2009 Dec; 33(12):1850-9. PubMed ID: 19898221
[TBL] [Abstract][Full Text] [Related]
29. Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas.
Thway K; Selfe J; Missiaglia E; Fisher C; Shipley J
J Clin Pathol; 2011 Jul; 64(7):587-91. PubMed ID: 21493758
[TBL] [Abstract][Full Text] [Related]
30. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
Hornick JL; Nielsen GP
Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
[TBL] [Abstract][Full Text] [Related]
31. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract][Full Text] [Related]
32. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
[TBL] [Abstract][Full Text] [Related]
33. Clinical relevance of molecular genetics to paediatric sarcomas.
Slater O; Shipley J
J Clin Pathol; 2007 Nov; 60(11):1187-94. PubMed ID: 17468291
[TBL] [Abstract][Full Text] [Related]
34. Intergroup Rhabdomyosarcoma Study: update for pathologists.
Qualman SJ; Coffin CM; Newton WA; Hojo H; Triche TJ; Parham DM; Crist WM
Pediatr Dev Pathol; 1998; 1(6):550-61. PubMed ID: 9724344
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of GEFT, a Rho family guanine nucleotide exchange factor, predicts poor prognosis in patients with rhabdomyosarcoma.
Sun C; Liu C; Li S; Li H; Wang Y; Xie Y; Li B; Cui X; Chen Y; Zhang W; Li F
Int J Clin Exp Pathol; 2014; 7(4):1606-15. PubMed ID: 24817957
[TBL] [Abstract][Full Text] [Related]
36. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case.
Gordon A; McManus A; Anderson J; Fisher C; Abe S; Nojima T; Pritchard-Jones K; Shipley J
Cancer Genet Cytogenet; 2003 Jan; 140(1):73-7. PubMed ID: 12550764
[TBL] [Abstract][Full Text] [Related]
38. Update on Myogenic Sarcomas.
Agaram NP
Surg Pathol Clin; 2019 Mar; 12(1):51-62. PubMed ID: 30709448
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyosarcomas and other soft tissue sarcomas in pediatric patients.
Parham DM
Curr Opin Oncol; 1993 Jul; 5(4):672-7. PubMed ID: 8364084
[TBL] [Abstract][Full Text] [Related]
40. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
